Trial Profile
A retrospective,cohort study to determine potential benefit of Etanercept to reduce risk of cancer in Taiwanese patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Mar 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Cancer; Rheumatoid arthritis
- Focus Therapeutic Use
- 30 Mar 2017 New trial record
- 01 Feb 2017 Results published in the Medicine